- Trials with a EudraCT protocol (41)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
41 result(s) found for: Glandular.
Displaying page 1 of 3.
EudraCT Number: 2009-017378-19 | Sponsor Protocol Number: RDT-NTBo-01 | Start Date*: 2011-09-27 | |||||||||||
Sponsor Name:Dr. Antonio Mari Roig | |||||||||||||
Full Title: Estudio prospectivo controlado sobre el efecto protector de la toxina botulínica tipo a en la sialoadenitis radioinducida | |||||||||||||
Medical condition: Con este estudio se pretende valorar el posible efecto de radioprotección glandular de la inyección de toxina botulínica previa al inicio del tratamiento con radioterapia debido a la disminución en... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005607-13 | Sponsor Protocol Number: NN8640-4467 | Start Date*: 2022-07-15 | ||||||||||||||||||||||||||
Sponsor Name:NOVO NORDISK. S.P.A. | ||||||||||||||||||||||||||||
Full Title: A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long-term safety of somapacitan in a basket study design in children with ... | ||||||||||||||||||||||||||||
Medical condition: Short stature born small for gestational age Turner syndrome Noonan syndrome Idiopathic short stature | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) SI (Ongoing) IE (Completed) DE (Ongoing) FI (Ongoing) GR (Ongoing) NL (Ongoing) BE (Ongoing) AT (Ongoing) ES (Ongoing) PT (Ongoing) BG (Ongoing) PL (Ongoing) LV (Ongoing) HR (Ongoing) LT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021430-64 | Sponsor Protocol Number: RR10/9389 | Start Date*: 2010-12-03 | |||||||||||
Sponsor Name:University of Leeds | |||||||||||||
Full Title: A randomised double blind placebo controlled clinical trial of anti B-cell therapy in patients with primary Sjögren’s syndrome. | |||||||||||||
Medical condition: Primary Sjögren’s syndrome (PSS). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000128-33 | Sponsor Protocol Number: 17700 | Start Date*: 2018-05-18 | ||||||||||||||||
Sponsor Name:Bayer AG | ||||||||||||||||||
Full Title: Multi-center, randomized, comparator-controlled, single-blind, parallel-group study to investigate the pharmacodynamics, pharmacokinetics and safety of an intrauterine system (BAY 987443) with thre... | ||||||||||||||||||
Medical condition: Contraception | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: DE (Completed) GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-000285-36 | Sponsor Protocol Number: PILOTINA | Start Date*: 2006-04-01 | |||||||||||
Sponsor Name:ISTITUTI FISIOTERAPICI OSPITALIERI | |||||||||||||
Full Title: Protocol for a pilot study examining the impact of Metformin use on serum testosterone levels in postmenopausal women | |||||||||||||
Medical condition: HYPERANDROGENISM | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004993-40 | Sponsor Protocol Number: MK-0431-081 | Start Date*: 2015-04-01 |
Sponsor Name:Merck & Co., Inc. | ||
Full Title: A Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Sitagliptin in Adolescents | ||
Medical condition: Type 2 Diabetes Mellitus | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2005-001073-94 | Sponsor Protocol Number: TH CR-202 | Start Date*: 2005-12-27 |
Sponsor Name:Threshold Pharmaceuticals Inc | ||
Full Title: A Randomised Phase 3, Double Blind, Placebo-Controlled Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia | ||
Medical condition: Benign Prostatic Hyperplasia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: HU (Ongoing) IT (Prematurely Ended) DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022255-37 | Sponsor Protocol Number: CHUBX2010/39 | Start Date*: 2010-09-29 | |||||||||||
Sponsor Name:CHU de Bordeaux | |||||||||||||
Full Title: Etude de l’efficacité et de la tolérance, de l’injection intra prostatique de toxine botulique A, chez l’homme, dans le traitement de l’hyperplasie bénigne de prostate symptomatique. | |||||||||||||
Medical condition: HBP symptomatique modérée à sévère selon le score IPSS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000511-77 | Sponsor Protocol Number: ACT16618 | Start Date*: 2020-11-12 | |||||||||||
Sponsor Name:Sanofi-Aventis Recherche & Développement | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, parallel-group study of the safety, tolerability, pharmacokinetics, and therapeutic efficacy of SAR441344 in adult patients with primary Sjögren’s s... | |||||||||||||
Medical condition: Sjögren’s syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000231-27 | Sponsor Protocol Number: NN8640-4263 | Start Date*: 2019-04-23 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: A trial comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® in children with growth hormone deficiency | |||||||||||||
Medical condition: Growth hormone deficiency in children | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) FR (Ongoing) DK (Completed) AT (Ongoing) SI (Ongoing) GB (GB - no longer in EU/EEA) NO (Ongoing) IE (Completed) EE (Completed) LV (Ongoing) PL (Ongoing) HU (Ongoing) ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002932-18 | Sponsor Protocol Number: 42756493-BLC3001 | Start Date*: 2018-02-08 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations | |||||||||||||
Medical condition: Advanced Urothelial Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Trial now transitioned) HU (Completed) ES (Ongoing) AT (Completed) FR (Trial now transitioned) DE (Ongoing) NL (Ongoing) PT (Ongoing) GR (Ongoing) PL (Completed) IT (Ongoing) DK (Ongoing) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001526-59 | Sponsor Protocol Number: CL2-95011-001 | Start Date*: 2020-10-20 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: A phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren’s Syndrome patients. An international, multicentre, randomised, double-blind, placebo-controlled study | |||||||||||||
Medical condition: Primary Sjögren’s Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) HU (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000232-10 | Sponsor Protocol Number: NN8640-4245 | Start Date*: 2019-05-15 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: A dose-finding trial evaluating the effect and safety of once-weekly treatment of somapacitan compared to daily Norditropin® in children with short stature born small for gestational age with no ca... | |||||||||||||
Medical condition: Short stature in children born small for gestational age with no catch-up growth by 2 years of age or older | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) FR (Ongoing) GB (GB - no longer in EU/EEA) AT (Ongoing) NO (Ongoing) IE (Completed) EE (Completed) HU (Trial now transitioned) LV (Ongoing) PL (Completed) ES (Prematurely Ended) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015723-90 | Sponsor Protocol Number: 2828/2009 | Start Date*: 2010-06-04 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: VARIATION OF PARATHYROID GLAND FOLLOWING CINACALCET USE IN DIALISYS PATIENTS WITH SONOGRAPHIC EVIDENCE OF SECONDARY HYPERPLASIA | |||||||||||||
Medical condition: secondary hyperparathyroidism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003506-26 | Sponsor Protocol Number: CI-331-19 | Start Date*: 2020-03-05 | |||||||||||||||||||||
Sponsor Name:Hospital Universitari Son Espases | |||||||||||||||||||||||
Full Title: Determination of Parathyroid Function by Fluorescence With Indocyanine Green (ICG) After Total Thyroidectomy | |||||||||||||||||||||||
Medical condition: Patients undergoing total thyroidectomy with visualization of the parathyroid glands under infrared light after intraoperative intravenous injection of 5 mg of indocyanine green to predict the poss... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001720-19 | Sponsor Protocol Number: XRS-ITRT-2018 | Start Date*: 2018-12-12 | |||||||||||
Sponsor Name:Institut de Terapia Regenerativa Tissular S.L. (ITRT) | |||||||||||||
Full Title: Phase II clinical trial to evaluate the effect and safety of MSV * in Xerostomia * adult autologous bone marrow mesenchymal stem cells, expanded under GMP of IBGM | |||||||||||||
Medical condition: Xerostomia post radiotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003447-34 | Sponsor Protocol Number: REQ-0000020479 | Start Date*: 2019-04-03 | |||||||||||
Sponsor Name:Hellenic Genitourinary Cancer Group (HGUCG) | |||||||||||||
Full Title: Nivolumab plus chemoradiotherapy in patients with muscle-invasive bladder cancer (MIBC) not undergoing cystectomy: a phase II, randomized study | |||||||||||||
Medical condition: muscle-invasive bladder cancer (MIBC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015558-40 | Sponsor Protocol Number: ABACEPT1 | Start Date*: 2010-07-28 | |||||||||||
Sponsor Name:University Medical Center Groningen | |||||||||||||
Full Title: Abatacept treatment in patients with primary Sjögren’s syndrome | |||||||||||||
Medical condition: Sjögren’s syndrome (SS) is a chronic, systemic, lymphoproliferative autoimmune disease affecting the exocrine glands. The salivary and lacrimal glands are most commonly affected, resulting in dry m... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005665-11 | Sponsor Protocol Number: KMD3213-IT-CL 0215 | Start Date*: 2006-03-23 | |||||||||||
Sponsor Name:Recordati S.p.A | |||||||||||||
Full Title: Evaluation Of The Efficacy And Safety Of Silodosin Vs. Tamsulosin And Placebo In The Treatment Of The Signs And Symptoms Of Benign Prostatic Hyperplasia. Multicentre, Randomised, Double-Blind, Cont... | |||||||||||||
Medical condition: Benign prostatic hyperplasia (BPH) is a non malignant enlargement of the prostate due to cellular hyperplasia of both glandular and stromal elements. As the prostate increases in size it may exert ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FI (Completed) GB (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011882-10 | Sponsor Protocol Number: GETUG-AFU 19/0901 | Start Date*: 2010-02-26 | |||||||||||
Sponsor Name:FNCLCC (Fédération Nationale des Centres de Lutte Contre le Cancer) | |||||||||||||
Full Title: Intensified methotrexate, vinblastine, doxorubicin and cisplatin (I-MVAC) with or without panitumumab as first-line treatment of advanced urothelial carcinoma in patients without H-Ras nor K-Ras mu... | |||||||||||||
Medical condition: Advanced urothelial carcinoma in patients without H-Ras nor K-Ras mutations | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.